WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006085838) 18-MEMBERED MACROCYCLES AND ANALOGS THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/085838    International Application No.:    PCT/US2005/002887
Publication Date: 17.08.2006 International Filing Date: 31.01.2005
IPC:
A01N 43/04 (2006.01), A61K 31/70 (2006.01)
Applicants: OPTIMER PHARMACEUTICALS, INC. [US/US]; 10110 Sorrento Valley Road, Suite C, San Diego, CA 92121 (US) (For All Designated States Except US).
SHUE, Youe-Kong [US/US]; (US) (For US Only).
HWANG, Chan-Kou [US/US]; (US) (For US Only).
CHIU, Yu-Hung [--/US]; (US) (For US Only).
ROMERO, Alex [US/US]; (US) (For US Only).
BABAKHANI, Farah [IR/US]; (US) (For US Only).
SEARS, Pamela [US/US]; (US) (For US Only).
OKUMU, Franklin [US/US]; (US) (For US Only)
Inventors: SHUE, Youe-Kong; (US).
HWANG, Chan-Kou; (US).
CHIU, Yu-Hung; (US).
ROMERO, Alex; (US).
BABAKHANI, Farah; (US).
SEARS, Pamela; (US).
OKUMU, Franklin; (US)
Agent: CHENG, Kent, H.; Cohen Pontani Lieberman & Pavane, 551 Fifth Avenue, Suite 1210, New York, NY 10176 (US)
Priority Data:
Title (EN) 18-MEMBERED MACROCYCLES AND ANALOGS THEREOF
(FR) MACROCYCLES A 18 CHAINONS ET LEURS ANALOGUES
Abstract: front page image
(EN)The present invention relates generally to the 18-membered macrocyclic antimicrobial agents called Tiacumicins, specifically, OPT-80 (which is composed almost entirely of the R-Tiacumicin B), pharmaceutical compositions comprising OPT-80, and methods using OPT-80. In particular, this compound is a potent drug for the treatment of bacterial infections, specifically C. difficile infections.
(FR)La présente invention se rapporte d'une manière générale aux agents anti-microbiens macrocycliques à 18 chaînons appelés tiacumicines, spécifiquement à l'OPT-80 (qui se compose presque entièrement de la R-tiacumicine B), à des compositions pharmaceutiques comprenant de l'OPT-80 et à des procédés d'utilisation de l'OPT-80. En particulier, ce composé est un médicament puissant pour le traitement des infections bactériennes, spécifiquement des infections à C. difficile.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)